Buy & Sell TG Therapeutics Inc (TGTX) – TG Therapeutics Inc Price Today
Aura AI Summary
Key Stats
- $6.04BMarket Cap
- HealthSector
- -12.82%3M Drawdown
- $6.28BEnterprise Value
- -Dividend Yield
- 8% Buy | 92% SellTrading Activity
- 8 daysTypical Hold Time
TG Therapeutics Inc (TGTX) is currently valued at a market capitalization of $6.04B, with an enterprise value of $6.28B. Over the past 52 weeks, TG Therapeutics Inc has traded between a low of $26.39 and a high of $43.14, highlighting its annual price range. Over the past three months, TG Therapeutics Inc has recorded a drawdown of -12.82%, reflecting recent price volatility. On average, investors hold TG Therapeutics Inc for approximately 8 days, indicating typical investor behavior on the platform.
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Most Recent News
S&P 500 gains driven by 'Magnificent 7' stocks; earnings growth expected to slow in 2027
The recent strong performance of the S&P 500 Index has been largely fueled by the 'Magnificent 7' mega-cap stocks. Earnings growth is expected to continue into 2026 but at a slower pace in 2027. Investors typically analyze forward-looking data over o...

EU agrees on trade deal with US including tariff safeguards amid Trump threats
The European Union reached a provisional agreement to implement a trade pact with the United States, including a safeguard mechanism allowing Brussels to suspend tariff cuts if US imports harm European industry. This deal aims to prevent the US from ...

Amazon seen with 10-15% upside due to strong AI investment and growing logistics, advertising platforms
Amazon is expected to have a 10-15% stock price upside driven by aggressive investments in AI capital expenditures and its leadership in long-term infrastructure. Concerns about excessive AI spending are overstated, as underinvestment could risk miss...
